Patients with ARVC carrying other DSG2 mutations or mutations in other genes were not recruited for this study, and therefore, whether NDPK-B and SK4 upregulation exist in other ARVC-patients with different gene mutations as well needs to be clarified in further studies. The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.